Strata Critical Medical, Inc. (SRTA)
4.69
+0.15
(+3.30%)
USD |
NASDAQ |
Oct 20, 16:00
4.69
0.00 (0.00%)
Pre-Market: 09:08
Strata Critical Medical Research and Development Expense (TTM) : 4.275M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.275M |
| March 31, 2026 | 3.965M |
| December 31, 2025 | 3.566M |
| September 30, 2025 | 3.627M |
| June 30, 2025 | 3.591M |
| March 31, 2025 | 3.866M |
| December 31, 2024 | 3.817M |
| September 30, 2024 | 3.046M |
| June 30, 2024 | 3.705M |
| Date | Value |
|---|---|
| March 31, 2024 | 4.174M |
| December 31, 2023 | 4.627M |
| September 30, 2023 | 5.261M |
| June 30, 2023 | 6.211M |
| March 31, 2023 | 5.833M |
| December 31, 2022 | 5.359M |
| September 30, 2022 | 4.696M |
| June 30, 2022 | 2.883M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median